INS and type 1 diabetes mellitus: Our findings from the 3 countries—combined with continued advances in and integration of devices such as smart insulin pens and caps and glucose monitoring systems, along with telemedicine and mobile health apps—lend support to the idea that a CES can contribute to improved, personalized, real-time self-care and clinical management of insulin-dependent diabetes globally [15].